| Value | ₹40.00 Cr |
|---|
BSE filing, NSE: ZODJRDMKJ. Summary written from the filing by ALFA Finder's alert engine.
Zodiac JRD MKJ Ltd: key numbers
- Share price
- ₹32.00
- Market cap
- ₹35.12 Cr
- Revenue (annual)
- ₹45.26 Cr
- Net profit (annual)
- ₹3.86 Cr
- P/E (TTM)
- 7.4×Sector 33.3×
- Promoter holding
- 31.07%-0.76% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Zodiac JRD MKJ Ltd
All →Zodiac JRD MKJ Capital Structure Change
Zodiac-JRD-MKJ received BSE in-principle approval for its Rights Issue and has convened a board meeting on 4 November 2026 to fix the issue price and record date. The issue was earlier approved for up to Rs 40 Crore.
Zodiac JRD MKJ Q2 FY27 Results: Net Profit ₹1 Cr, Up 100.0% YoY
Zodiac JRD MKJ Ltd reported revenue from operations of ₹10.3 Cr (+0.0% YoY) and net profit of ₹1 Cr (+100.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1 Cr · +100.0% YoY
Zodiac JRD MKJ Board Meeting Date
Zodiac-JRD-MKJ will hold a board meeting on 3 November 2026. It will consider unaudited financial results for the quarter and half year ended 30 September 2026.
Zodiac JRD MKJ Other Announcement
Zodiac-JRD-MKJ Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing reflects changes in the promoter list due to reclassification and death.
Zodiac JRD MKJ Other Announcement
Zodiac-JRD-MKJ Ltd has re-appointed Girish L. Shethia as Statutory Auditor for a term of 60 months. This is a routine administrative compliance.
Zodiac JRD MKJ Annual General Meeting
Zodiac-JRD-MKJ Limited conducted its 39th Annual General Meeting on September 24, 2026. Shareholders considered resolutions for financial statement adoption, auditor re-appointment, and an ESOP plan.
Other capital structure change announcements
All →Jyothy Labs Capital Structure Change
Jyothy Labs' board approved a Rs 147 Crore share buyback via tender offer at Rs 215 per share. The record date is November 11, 2026.
- Value
- ₹147.0 Cr
Evonile Pharma Capital Structure Change
Evonile Pharma's Rights Issue Committee fixed November 11, 2026 as record date for a partly paid rights issue of 1,02,87,832 shares at Rs.860 each. Issue size is Rs.8,847.54 Million, with issue opening November 19, 2026.
- Value
- ₹884.8 Cr
- Execution
- Issue opening 19 Nov 2026 to closing 3 Dec 2026; listing on or about 9 Dec 2026
Share India Securities Capital Structure Change
Share India Securities allotted 44,02,000 equity shares under its Silverleaf Capital amalgamation scheme. It also granted 3,80,500 employee stock options under ESOS-II.
Arvaya Healthcare Capital Structure Change
Arvaya Healthcare's board approved the draft letter of offer for a rights issue of partly paid-up equity shares up to ₹210 Crore, plus a postal ballot. The board outcome's main decision is the rights issue, so it is classified as a capital raise step.
- Value
- ₹210.0 Cr
Mittal Life Style Capital Structure Change
Mittal Life Style set 15 December 2026 as the record date for a 10:1 consolidation of its equity shares. No cash is paid.
Baba Arts Capital Structure Change
Skybridge Interactive LLP, a non-promoter acquirer, disclosed under Reg 29(2) that it acquired 65,00,000 shares of Baba Arts, raising its stake from 62.28% to 74.67%. The acquisition was off-market under a share purchase agreement dated 25 February 2026.